$60.00 $1.00 per serving
Product analysis
Joint Support Nutrients may offer modest joint-comfort support, but several preparations cannot be matched to those behind the suggested benefits. That makes the likely benefit of the combination less predictable.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality24
Several key preparations are unspecified, making comparisons with particular joint supplements difficult. The named glucosamine complex does not establish equivalence to preparations with clinical findings.
Ingredient Transparency75
Ingredient amounts are stated, helping compare servings. Most forms are unspecified, leaving important preparation differences unresolved.
Value For Money33
Curcumin and bromelain are expensive for the serving or amount supplied. Value for the remaining ingredients is uncertain.
Customer Satisfaction84
Customer ratings are strongly positive across more than a thousand reviews. The broad feedback supports satisfaction without proving joint or digestive benefits.
Product Focus66
The formula has a clear connection to joint comfort through several related ingredients. Limited evidence and preparation differences make its additional digestive and inflammation uses less certain.
- Format
Capsule - Container
- 240 Capsule(s)
- Per serving
- $1.00
- Customer rating
- 4.7 · 1,717 ratings
Goals
Impact
Moderate effect
Boswellia · 350 mgCurcumin · 250 mg
Impact
High effect
Boswellia · 350 mgCurcumin · 250 mg
MSM may modestly support comfort in people with knee discomfort, while boswellia and curcumin have limited osteoarthritis symptom findings. The 850 mg MSM serving is below the amounts used in the supplied trials. The glucosamine sulfate, boswellia and curcumin preparations are not verified equivalents of those studied, limiting transfer of benefits. Turmeric presence remains unresolved.
How this product is rated for Joint Health
Ingredient fit68
MSM, boswellia and curcumin provide the relevant joint-related ingredients within a broader formulation. The serving provides partial amounts relative to the comparison references, including MSM below the supplied trial regimens.
Goal fit
MSM, boswellia and curcumin provide the relevant joint-related ingredients within a broader formulation.
Dose adequacy
The serving provides partial amounts relative to the comparison references, including MSM below the supplied trial regimens.
Pathways50
The main identified contribution concerns inflammation-related joint symptoms, with weaker cartilage-matrix findings.
Depth
The main identified contribution concerns inflammation-related joint symptoms, with weaker cartilage-matrix findings.
Breadth
Only inflammation-related support reached the saved coverage requirement; broad joint support was not established.
Evidence60
MSM leads the saved evidence finding, with only modest symptom changes in small studies. Glucosamine sulfate, boswellia and curcumin lack verified matches to the specifically studied preparations.
Evidence strength
MSM leads the saved evidence finding, with only modest symptom changes in small studies.
Studied preparation
Glucosamine sulfate, boswellia and curcumin lack verified matches to the specifically studied preparations.
Formulation logic100
No missing ingredient partner requirement was identified. None of the evaluated ingredient conflicts was identified.
Partner coverage
No missing ingredient partner requirement was identified.
Conflicts
None of the evaluated ingredient conflicts was identified.
Effective doses
All included ingredients reach the saved minimum amount requirement; that does not establish a clinically effective regimen.
Impact
High effect
Bromelain · 200 mgBoswellia · 350 mgCurcumin · 250 mg
Bromelain is a protein-digesting enzyme, but the supplied evidence does not establish that its isolated amount improves digestive symptoms. Boswellia does not have convincing routine digestive-outcome evidence, and the curcumin declaration cannot be matched to a studied preparation and amount basis. Turmeric’s presence remains unresolved, so its preparation-specific findings cannot be transferred to this product.
How this product is rated for Gut Health
Ingredient fit59
Digestive-related nutrients or botanicals sit within a broader formula that also serves other purposes.
Goal fit
Digestive-related nutrients or botanicals sit within a broader formula that also serves other purposes.
Dose adequacy
The contributing amounts receive partial support relative to the supplied references; preparation and population limitations still matter.
Pathways66
The strongest represented route is gut inflammation resolution; this describes the saved ingredient mapping rather than a demonstrated symptom response.
Depth
The strongest represented route is gut inflammation resolution; this describes the saved ingredient mapping rather than a demonstrated symptom response.
Breadth
Two digestive routes are represented in the saved findings; this does not demonstrate broad relief across digestive symptoms.
Evidence81
Boswellia leads the saved comparison, despite supplied limitations that do not establish routine digestive benefit.
Evidence strength
Boswellia leads the saved comparison, despite supplied limitations that do not establish routine digestive benefit.
Studied preparation
The contributing preparations meet the saved criteria; supplied scientific context still limits transfer to routine digestive outcomes.
Formulation logic100
No required partner is missing among the contributing ingredients; this does not establish additional benefit from combining them. No configured ingredient conflict was identified in the supplied findings.
Partner coverage
No required partner is missing among the contributing ingredients; this does not establish additional benefit from combining them.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
All contributing ingredients meet the saved amount criterion; excluded ingredients are not thereby included, and the criterion does not establish clinical efficacy.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Potassium (Glucosamine Sulfate Potassium Chloride Complex) | 98 mg | |
Methyl Sulfonyl Methane | 850 mg | |
Glucosamine Sulfate (Glucosamine Sulfate Potassium Chloride Complex) | 750 mg | |
Indian Frankincense extract | 350 mg | |
Curcumin Phytosome Complex | 250 mg | |
Bromelain | 200 mg |
Boswellia · 350 mg OverallScore30
The serving lists 350 mg of boswellia. The boswellic acid percentage is not stated. A boswellia-specific value conclusion is unavailable.
How this ingredient is rated
Composition and Label Disclosure0
The boswellic acid percentage is not stated.
Marker and Preparation Disclosure
The boswellic acid percentage is not stated.
Composition and Label Disclosure60
The serving lists 350 mg of boswellia.
Boswellia Amount and Marker Disclosure
The serving lists 350 mg of boswellia.
Commercial Price and Usability
A boswellia-specific value conclusion is unavailable.
Curcumin · 250 mg OverallScore16
A serving lists 250 mg of curcumin phytosome. The whole-product cost per serving is relatively high. The active curcuminoid amount is unclear; preparation weight does not establish it.
How this ingredient is rated
Composition and Label Disclosure30
The active curcuminoid amount is unclear; preparation weight does not establish it.
Curcuminoid Amount Disclosure
The active curcuminoid amount is unclear; preparation weight does not establish it.
Composition and Label Disclosure0
The active amount and purity testing details are unavailable.
Preparation and Marker Disclosure
The active amount and purity testing details are unavailable.
Commercial Price and Usability20
The whole-product cost per serving is relatively high.
Commercial Price per Labeled Serving
The whole-product cost per serving is relatively high.
Bromelain · 200 mg OverallScore37
The serving provides 200 mg of bromelain, with a high whole-product cost relative to that amount. The available information does not state bromelain activity in GDU or MCU. The botanical source is unspecified in the available information. The price may overstate bromelain's own cost.
How this ingredient is rated
Composition and Label Disclosure36
The available information does not state bromelain activity in GDU or MCU.
Enzyme Activity Disclosure
The available information does not state bromelain activity in GDU or MCU.
Declared GDU per Gram
A direct GDU per gram concentration is not available.
Composition and Label Disclosure47
The declared serving contains 200 mg of bromelain. The botanical source is unspecified in the available information.
Declared Bromelain Mass
The declared serving contains 200 mg of bromelain.
Botanical Source Disclosure
The botanical source is unspecified in the available information.
Commercial Price and Usability20
The whole-product price is high relative to the declared bromelain amount; this can overstate the cost of bromelain itself.
Cost per 500 mg Declared Bromelain
The whole-product price is high relative to the declared bromelain amount; this can overstate the cost of bromelain itself.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Positive Effects of a Lecithin-Based Delivery Form of Boswellia serrata Extract in Acute Diarrhea of Adult Subjects.
- Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal.
- Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome.
- Interventions for treating collagenous colitis.
- Interventions for treating collagenous colitis.
- The role of enzyme supplementation in digestive disorders.
- Effects of bromelain supplementation on disease activity and quality of life in patients with ulcerative colitis: a randomized, triple-blind, placebo-controlled study.
- Curcuminoids for Metabolic Syndrome: Meta-Analysis Evidences Toward Personalized Prevention and Treatment Management.
- [Curcumin in children with autism spectrum disorder: systemic inflammation, sensory regulation, and gut-brain interaction disorders. A randomized, double-blind, placebo-controlled clinical trial (CURATEA)].
- Curcumin supplementation during high-altitude exposure modulates body composition and its relationship with gut microbiota: a randomized controlled trial.
- Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies.
- Turmeric for Treatment of Irritable Bowel Syndrome: A Systematic Review of Population-Based Evidence.
- Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
- A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
- Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
- A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
- A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
- Therapeutic efficacy of bromelain in impacted third molar surgery: a randomized controlled clinical study.
- Efficacy of proteolytic enzyme bromelain on health outcomes after third molar surgery. Systematic review and meta-analysis of randomized clinical trials.
- Placebo-controlled randomized clinical trial on the immunomodulating activities of low- and high-dose bromelain after oral administration - new evidence on the antiinflammatory mode of action of bromelain.